Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kazumasa Akagi"'
Autor:
Fumiko Hayashi, Kazumasa Akagi, Hirokazu Taniguchi, Toyoshi Matsutake, Hiromi Kawahara, Ichiro Sekine, Hiroshi Gyotoku, Shinnosuke Takemoto, Hiroshi Soda, Kazuto Ashizawa, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 14, Iss 36, Pp 3556-3560 (2023)
Abstract Lung spindle cell carcinoma is an aggressive subtype of pleomorphic lung cancer resistant to cytotoxic chemotherapy. Programmed cell death‐1 (PD‐1) inhibitors have been reported to have clinical effects in patients with spindle cell carc
Externí odkaz:
https://doaj.org/article/b58ed8ee3b224b079a3224e4769cff4c
Autor:
Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima, Kazumasa Akagi, Sawana Ono, Yasuhiro Umeyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Yasushi Hisamatsu, Ryotaro Morinaga, Ryuta Tagawa, Ryosuke Ogata, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Katsumi Nakatomi, Fumiko Hayashi, Nanae Sugasaki, Akitoshi Kinoshita, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 14, Iss 28, Pp 2890-2894 (2023)
Abstract Introduction Combined treatment using anti‐programmed death‐ligand 1 antibody (anti‐PD‐L1) and platinum‐etoposide is the current standard first‐line treatment for patients with extensive‐stage (ES) small cell lung cancer (SCLC)
Externí odkaz:
https://doaj.org/article/58002b57502d40c3b42c6726aa5a9340
Autor:
Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, Takuya Yamazaki, Sawana Ono, Hiromi Tomono, Takayuki Suyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Hiroyuki Yamaguchi, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Takashi Mizowaki, Yoshio Monzen, Takaya Ikeda, Seiji Nagashima, Yutaro Tasaki, Daisuke Nakamura, Kazutoshi Komiya, Katsumi Nakatomi, Eisuke Sasaki, Koichi Hirakawa, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 13, Iss 16, Pp 2404-2409 (2022)
Abstract Background Etoposide plus cisplatin (EP) combined with concurrent accelerated hyperfractionated thoracic radiotherapy (AHTRT) is the standard treatment strategy for unresectable limited‐disease (LD) small cell lung cancer (SCLC), which has
Externí odkaz:
https://doaj.org/article/e98bad858982435187389e1927d39f13
Autor:
Shinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, Hiromi Tomono, Noritaka Honda, Takayuki Suyama, Yasuhiro Umeyama, Yosuke Dotsu, Hirokazu Taniguchi, Daiki Ogawara, Hiroaki Senju, Hiroshi Gyotoku, Nanae Sugasaki, Hiroyuki Yamaguchi, Katsumi Nakatomi, Minoru Fukuda, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2300-2306 (2021)
Abstract Background S‐1 and pemetrexed (PEM) are key treatments for non‐small cell lung cancer (NSCLC). However, the mechanism of anticancer activity of S‐1 and PEM is similar. Cross‐resistance between S‐1 and PEM is of concern. This explor
Externí odkaz:
https://doaj.org/article/602db2692a2a4097822cef7b5d6f304e
Autor:
Kazumasa Akagi, Kazuko Yamamoto, Asuka Umemura, Shotaro Ide, Tatsuro Hirayama, Takahiro Takazono, Yoshifumi Imamura, Taiga Miyazaki, Noriho Sakamoto, Hirokazu Shiraishi, Hideaki Takahata, Yoshiaki Zaizen, Junya Fukuoka, Minoru Morikawa, Kazuto Ashizawa, Katsuji Teruya, Koichi Izumikawa, Hiroshi Mukae
Publikováno v:
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-7 (2020)
Abstract Background Vacuolar encephalomyelopathy, a disregarded diagnosis lately, was a major neurological disease in the terminal stages of human immunodeficiency virus (HIV)-1 infection in the pre-antiretroviral therapy (ART) era. Granulomatous-lym
Externí odkaz:
https://doaj.org/article/f55667d5b8a4451ea043a417a5e95ded
Autor:
Kazumasa Akagi, Taiga Miyazaki, Kazuhiro Oshima, Asuka Umemura, Satoshi Shimada, Kouichi Morita, Hiroaki Senju, Masato Tashiro, Takahiro Takazono, Tomomi Saijo, Shintaro Kurihara, Motohiro Sekino, Kazuko Yamamoto, Yoshifumi Imamura, Koichi Izumikawa, Katsunori Yanagihara, Akihiko Uda, Shigeru Morikawa, Tomoki Yoshikawa, Takeshi Kurosu, Masayuki Shimojima, Masayuki Saijo, Hiroshi Mukae
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that commonly has a lethal course caused by the tick-borne Huaiyangshan banyang virus [former SFTS virus (SFTSV)]. The viral load in various body
Externí odkaz:
https://doaj.org/article/400bbe3e14e846a6ae1c5a0bd0441c1e
Autor:
Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, Takaya Ikeda, Kazumasa Akagi, Hiromi Tomono, Yasuhiro Umeyama, Yosuke Dotsu, Hirokazu Taniguchi, Hiroshi Gyotoku, Hiroaki Senju, Takeshi Kitazaki, Katsumi Nakatomi, Seiji Nagashima, Masaaki Fukuda, Akitoshi Kinoshita, Hiroshi Soda, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 389-393 (2020)
Introduction Anti‐vascular endothelial growth factor therapy has been shown to be effective in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusion (MPE); however, there are no data to suggest that ramucirumab has the same
Externí odkaz:
https://doaj.org/article/d24e897c795f4ec7ae6caea7a72c8675
Autor:
Kazumasa Akagi, Toyoshi Matsutake, Kiyoyasu Fukushima, Hiroshi Mukae, Hirokazu Kurohama, Hirofumi Matsumoto
Publikováno v:
Respiratory Medicine Case Reports, Vol 33, Iss , Pp 101384- (2021)
A 69-year-old man presented with a left pleural effusion. Even after repeated drainage, the pleural effusion had been increasing for more than two years. Thoracoscopy unexpectedly showed a pleural mass on the parietal pleura, and it was completely re
Externí odkaz:
https://doaj.org/article/1afd8ae39b1049cf832c00b21a03bd87
Autor:
Kazumasa Akagi, Shigehiro Yagishita, Mayu Ohuchi, Yoshiharu Hayashi, Yuki Takeyasu, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Hiroshi Mukae, Yuichiro Ohe, Akinobu Hamada
Publikováno v:
Lung Cancer. 178:247-253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc254cf177323491870321213c57ab01
https://doi.org/10.1016/j.lungcan.2023.03.001
https://doi.org/10.1016/j.lungcan.2023.03.001
Autor:
Mayu, Ohuchi, Shigehiro, Yagishita, Hitomi, Jo, Kazumasa, Akagi, Ryoko, Inaba Higashiyama, Ken, Masuda, Yuki, Shinno, Yusuke, Okuma, Tatsuya, Yoshida, Yasushi, Goto, Hidehito, Horinouchi, Yoshinori, Makino, Noboru, Yamamoto, Yuichiro, Ohe, Akinobu, Hamada
Publikováno v:
Lung Cancer. 173:35-42
The dosing pattern of pembrolizumab is based on population pharmacokinetic (Pop-PK) analysis of clinical trials. Data for Japanese patients or patient populations with poor conditions such as cachexia are scarce. In this study, we performed a Pop-PK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed333cd0313c498d1f1ffd06b17ec668
https://doi.org/10.1016/j.lungcan.2022.08.018
https://doi.org/10.1016/j.lungcan.2022.08.018